Peter S. Kim, Director at Entrada Therapeutics, Inc. (TRDA), bought 25,000 shares at $14.59 ($365K) on 2024-05-14, disclosed to the SEC on 2024-05-16.
Open-market purchase of $365k TRDA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| TRDA | BUY | 2024-04-10 | $35K | — | Filing → |
| TRDA | BUY | 2024-04-01 | $21K | — | Filing → |
| TRDA | BUY | 2024-03-26 | $123K | — | Filing → |